Clinical Trial Update: Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate Hypertension [Phase 3]

View source ↗

Summary

Phase 3 clinical trial updates for irbesartan/hydrochlorothiazide and irbesartan in treating mild to moderate hypertension have completed. The sponsor listed is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Irbesartan (irbesartan)
• Irbesartan/Hydrochlorothiazide (irbesartan/hydrochlorothiazide)

Snippet

Sponsor: Sanofi | Conditions: Hypertension | Phase 3 | Status: COMPLETED